サポート>ブログ>抗原認識とB細胞活性化:詳細な解説

抗原認識とB細胞活性化:詳細な解説

Biointron 2024-03-06
Antibodies.jpg
Image credit: MDPI

Antigens are foreign molecules or molecular structures found on various invaders, including bacteria, viruses, parasites, and even toxins. These foreign entities trigger an immune response by the body's defense system to eliminate them.

Antigens exhibit remarkable diversity in structure, ranging from complex proteins and polysaccharides (sugars) like those found on bacterial cell walls, to simpler molecules like lipids (fats) on the outer membrane of some viruses. Additionally, carbohydrates can also be recognized as antigens, particularly by B cells in collaboration with T cells. 

B cells, a type of lymphocyte, play a crucial role in the adaptive immune response by producing antibodies, specialized proteins designed to neutralize specific antigens. Before antibodies can be produced, B cells need to first recognize and bind to the antigen. This recognition is mediated by B cell receptors (BCRs), Y-shaped proteins embedded in the B cell's membrane.1,2 

Each B cell expresses a unique BCR, generated through a complex process called V(D)J recombination. This unique BCR has a specific antigen-binding site shaped like a pocket, known as the Fab fragment. The complementary shape of an antigen, also known as the epitope, can perfectly fit into this pocket, leading to a highly specific and tight binding. This specificity ensures that B cells only respond to specific antigens and not to healthy body molecules, preventing autoimmunity.3

While membrane-bound antigens on the surface of pathogens are common triggers for B cell activation, soluble antigens not bound to a membrane can also stimulate B cells, especially in collaboration with antigen-presenting cells (APCs) like macrophages and dendritic cells. APCs internalize soluble antigens, process them, and present fragments on their surface complexed with major histocompatibility complex (MHC) class II molecules. These MHC-antigen complexes can then be recognized by T helper cells, which provide additional signals to activate B cells, leading to a more robust immune response. 

Following antigen binding and potential T cell help, B cells undergo a complex process of activation. This activation involves a cascade of intracellular signaling pathways, ultimately leading to clonal expansion (rapid division) and differentiation into various types of cells: 

  • Plasma cells: These specialized cells dedicate their entire machinery to producing large quantities of antibodies tailored to neutralize the encountered antigen. 

  • Memory B cells: These long-lived cells remain dormant but retain the memory of the specific antigen. Upon future exposure to the same antigen, they can rapidly differentiate into plasma cells, providing long-term immunity.4

Therefore, antigen recognition and B cell activation are crucial steps in the humoral immune response, orchestrating the generation of specific antibodies to combat invading pathogens and maintain immune memory for future encounters. 


References

  1. Janeway Jr, C. A. (2001). Immunobiology: The immune system in health and disease (5th ed.). Garland Science. 

  2. Batista, F. D., & Harwood, N. E. (2009). The who, how and where of antigen presentation to B cells. Nature Reviews Immunology, 9(1), 15-27. https://doi.org/10.1038/nri2454

  3. Vos, Q., Lees, A., Wu, Z., Snapper, C. M., & Mond, J. J. (2000). B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunological Reviews, 176(1), 154-170. https://doi.org/10.1034/j.1600-065X.2000.00607.x

  4. Hoffman, W., Lakkis, F. G., & Chalasani, G. (2016). B Cells, Antibodies, and More. Clinical Journal of the American Society of Nephrology : CJASN, 11(1), 137-154. https://doi.org/10.2215/CJN.09430915


Subscribe to our ブログ
Recommended Articles
人間の免疫システムの活用:自然な防御から精密医療へ

免疫・PAMP/DAMP・革新的抗体療法の解説

Aug 08, 2025
抗体薬物複合体(ADC)の基礎レビュー:作用機序、臨床進展、設計最適化、課題、および将来

抗体薬物複合体(Antibody-Drug Conjugates, ADC)は、がん治療において革新的なターゲット型治療薬の一つであり、モノクローナル抗体(mA……

Aug 05, 2025
抗体機能におけるFc糖鎖の役割

抗体の機能は、Fc領域の糖鎖修飾状態に大きく依存しています。

Jun 25, 2025
AIS 2025 – フランス:ハイライトとイベント総括

第13回抗体産業シンポジウム(Antibody Industrial Symposium 2025)が、2025年6月25日から26日にかけてフランス・トゥール……

Jun 22, 2025

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。